Phan Stephanie V
University of Georgia College of Pharmacy, Albany, GA, USA
Int J Psychiatry Med. 2016;51(2):211-9. doi: 10.1177/0091217416636601.
Medication nonadherence is common among patients with schizophrenia and due to a variety of factors including lack of insight, psychopathology, substance use disorder, issues associated with treatment, stigma, fragmentation of care, cultural influences, and socioeconomic status. Among this population, nonadherence is problematic because it can lead to decompensation or exacerbation of symptoms, relapse, rehospitalization or greater use of emergency psychiatric services, functional decline, and increased risk of death. Psychoeducational approaches alone are ineffective, but in combination with behavioral interventions, appear to be effective. Involving the patient's support system, in addition to other interventions, can improve treatment adherence. Many medication-related factors, such as effectiveness and tolerability of antipsychotics, regimen complexity, and past medication trials impact appropriate medication use. Therefore, optimizing the patient's pharmacotherapeutic regimens can improve adherence. Additional factors favorably influencing adherence include involving the patient in their treatment, fostering a therapeutic alliance, implementing/using reminder systems, and addressing substance use disorder. Medication nonadherence arises from multiple reasons that vary between patients. Thus, the most effective strategies to improve adherence are multifactorial and may involve both psychoeducational and behavioral techniques, as well as previously listed approaches. Strategies should be targeted toward the patient and their support system, whenever possible, to further improve the chances of appropriate medication use. Recognizing that all patients with schizophrenia are at risk for medication nonadherence is important. No one technique has been shown to be most effective; therefore, the risk for nonadherence should continually be assessed and multiple strategies should be targeted to the patient (and caregiver) and repeatedly implemented throughout the course of the patient's illness.
药物治疗不依从在精神分裂症患者中很常见,其原因多种多样,包括缺乏洞察力、精神病理学、物质使用障碍、与治疗相关的问题、耻辱感、护理碎片化、文化影响以及社会经济地位等。在这一人群中,不依从是个问题,因为它会导致症状失代偿或加重、复发、再次住院或更多地使用紧急精神科服务、功能衰退以及死亡风险增加。仅采用心理教育方法是无效的,但与行为干预相结合似乎是有效的。除其他干预措施外,让患者的支持系统参与进来可以提高治疗依从性。许多与药物相关的因素,如抗精神病药物的有效性和耐受性、治疗方案的复杂性以及过去的药物试验等,都会影响适当的药物使用。因此,优化患者的药物治疗方案可以提高依从性。其他有利于提高依从性的因素包括让患者参与其治疗、建立治疗联盟、实施/使用提醒系统以及解决物质使用障碍问题。药物治疗不依从的原因多种多样,因人而异。因此,提高依从性的最有效策略是多因素的,可能涉及心理教育和行为技巧以及前面列出的方法。只要有可能,策略应针对患者及其支持系统,以进一步提高适当用药的机会。认识到所有精神分裂症患者都有药物治疗不依从的风险很重要。没有一种技术被证明是最有效的;因此,应持续评估不依从的风险,并针对患者(及其照顾者)采取多种策略,并在患者病程中反复实施。